Judge Finds Drug Makers Liable For Inflating Costs

Law360, New York (June 21, 2007, 12:00 AM EDT) -- A federal judge has issued a stinging rebuke to three pharmaceutical companies in a massive antitrust class action, finding that they acted unfairly and deceptively by causing the publication of artificially inflated average wholesale prices for various prescription drugs.

After a twenty-day bench trial, U.S. District Judge Patti B. Saris said in findings of fact and conclusions of law filed Thursday that AstraZeneca, Bristol-Myers Squibb Co. and Schering-Plough Corp., a subsidiary of Warrick, inflated the AWP for the drugs, which grossly exceeded actual physician acquisition costs....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.